首页 | 本学科首页   官方微博 | 高级检索  
     


Establishment of a cloned line of Lewis lung carcinoma cells adapted to cell culture
Authors:John S. Bertram  Przemyslaw Janik
Affiliation:1. Department of Experimental Therapeutics, Roswell Park Memorial Institute, New York State Department of Health, Buffalo, New York 14263 U.S.A.;2. Grace Cancer Drug Center, Roswell Park Memorial Institute, New York State Department of Health, Buffalo, New York 14263 U.S.A.
Abstract:A cloned line of cells adapted to culture has been isolated from the Lewis Lung Carcinoma and has been designated the Lewis lung carcinoma line 1 (LLC1). It grows as a monolayer culture in RPMI 1640 medium supplemented with 2% fetal calf serum with a plating efficiency of about 94% and a doubling time of 21 h. LLC1 cells remain highly tumorigenic in C57B1 mice and produce primary tumors and lung metastases histologically indistinguishable from the original tumor line. The doubling time for a subcutaneous tumor derived from LLC1 cells was 23 h for a tumor mass of about 0.1 g and 40 h for a tumor mass of about 1 g. The cell line forms discrete colonies on a plastic substrate and can be used in a focus assay to determine drug induced cytotoxicity. Results with a number of chemotherapeutic agents are reported; in general, sensitivity measured in vitro does not correspond with published reports of sensitivity of the Lewis Lung carcinoma in vivo.
Keywords:LLCL1, Lewis lung carcinoma line 1  LLC, Lewis lung carcinoma  BME, basal medium Eagle's with Earle's salts  RPMI 1640, Roswell Park Memorial Institute medium 1640  HIFCS, heat-inactivated fetal calf serum  PBS, phosphate buffered saline  5-FU, 5-fluorouracil  ara-C, cytosine arabinoside  1,3-bis(2-chloroethyl)-1-nitrosourea
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号